{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:26:27Z","timestamp":1791084387971,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,8,23]],"date-time":"2004-08-23T00:00:00Z","timestamp":1093219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,8,23]],"date-time":"2004-08-23T00:00:00Z","timestamp":1093219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,10,1]]},"DOI":"10.1038\/sj.bmt.1704645","type":"journal-article","created":{"date-parts":[[2004,8,23]],"date-time":"2004-08-23T09:17:30Z","timestamp":1093252650000},"page":"721-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":199,"title":["Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant"],"prefix":"10.1038","volume":"34","author":[{"given":"M","family":"Eapen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-J","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D I","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B M","family":"Camitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C N","family":"Bredeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R P","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"deLima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,8,23]]},"reference":[{"key":"BF1704645_CR1","first-page":"269","volume":"9","author":"M Mrsic","year":"1992","unstructured":"Mrsic M, Horowitz MM, Atkinson K et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269\u2013275.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704645_CR2","first-page":"50","volume":"7","author":"L Kumar","year":"1994","unstructured":"Kumar L . Management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994; 7: 50\u201357.","journal-title":"J Clin Oncol"},{"key":"BF1704645_CR3","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1200\/JCO.2001.19.16.3675","volume":"9","author":"A Bosi","year":"2001","unstructured":"Bosi A, Laszlo D, Labopin M et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European cooperative group for blood and marrow transplantation. J Clin Oncol 2001; 9: 3675\u20133684.","journal-title":"J Clin Oncol"},{"key":"BF1704645_CR4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","volume":"86","author":"S Mackinnon","year":"1995","unstructured":"Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-host disease. Blood 1995; 86: 1261\u20131268.","journal-title":"Blood"},{"key":"BF1704645_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/sj.bmt.1700762","volume":"19","author":"A Bacigalupo","year":"1995","unstructured":"Bacigalupo A, Soracco M, Vassallo F et al. Donor lymphocyte infusion (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 19: 927\u2013932.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704645_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins","year":"1997","unstructured":"Collins RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433\u2013444.","journal-title":"J Clin Oncol"},{"key":"BF1704645_CR7","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S0301-472X(99)00096-X","volume":"27","author":"F Dazzi","year":"1999","unstructured":"Dazzi F, Szydlo R, Goldman J et al. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand. Exp Haematol 1999; 27: 1477\u20131486.","journal-title":"Exp Haematol"},{"key":"BF1704645_CR8","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood.V96.8.2712","volume":"96","author":"F Dazzi","year":"2000","unstructured":"Dazzi F, Szydlo RM, Cross NCP et al. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 2000; 96: 2712\u20132716.","journal-title":"Blood"},{"key":"BF1704645_CR9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood.V95.8.2645","volume":"95","author":"DL Porter","year":"2000","unstructured":"Porter DL, Collins RH, Hardy C et al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000; 95: 1214\u20131221.","journal-title":"Blood"},{"key":"BF1704645_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/bbmt.2001.v7.pm11215696","volume":"7","author":"S Carlens","year":"2001","unstructured":"Carlens S, Remberger M, Ascham J, Ringd\u00e9n O . The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse. Biol Blood Marrow Transplant 2001; 7: 31\u201338.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704645_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1200\/JCO.2002.20.2.405","volume":"20","author":"JE Levine","year":"2000","unstructured":"Levine JE, Braun T, Penza SL et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem cell transplant. J Clin Oncol 2000; 20: 405\u2013412.","journal-title":"J Clin Oncol"},{"key":"BF1704645_CR12","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1182\/blood.V100.5.1590.h81702001590_1590_1595","volume":"100","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, O'Brien S, Cortes JE et al. Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 2000; 100: 1590\u20131595.","journal-title":"Blood"},{"key":"BF1704645_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2141.1991.tb08083.x","volume":"79","author":"AJ Barrett","year":"1991","unstructured":"Barrett AJ, Locatelli F, Treleaven JG et al. Second transplants for leukemic relapse after bone marrow transplantation: high early mortality but favorable effect of chronic GVHD on continued remission. Br J Haematol 1991; 79: 567\u2013574.","journal-title":"Br J Haematol"},{"key":"BF1704645_CR14","first-page":"205","volume":"9","author":"JE Wagner","year":"1992","unstructured":"Wagner JE, Vogelsang GB, Zehnbauer BA et al. Relapse of leukemia after bone marrow transplantation: effect of second myeloabalative therapy. Bone Marrow Transplant 1992; 9: 205\u2013209.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704645_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.1993.11.2.304","volume":"11","author":"JP Radich","year":"1993","unstructured":"Radich JP, Sanders JE, Buckner CD et al. Second allogeneic transplantation for patients with recurrent leukemia after initial transplantation with total body irradiation-containing regimen. J Clin Oncol 1993; 11: 304\u2013313.","journal-title":"J Clin Oncol"},{"key":"BF1704645_CR16","first-page":"589","volume":"14","author":"R Martino","year":"1994","unstructured":"Martino R, Badell I, Brunet S et al. Second bone marrow transplantation for leukemia in untreated relapse. Bone Marrow Transplant 1994; 14: 589\u2013593.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704645_CR17","first-page":"39","volume":"17","author":"K-Y Chaing","year":"1996","unstructured":"Chaing K-Y, Weisdorf DJ, Davies SM et al. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplant 1996; 17: 39\u201342.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704645_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/sj.leu.2400585","volume":"11","author":"A Bosi","year":"1997","unstructured":"Bosi A, Bacci S, Miniero R et al. Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO). Leukemia 1997; 11: 420\u2013424.","journal-title":"Leukemia"},{"key":"BF1704645_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/sj.bmt.1700680","volume":"19","author":"K Kishi","year":"1997","unstructured":"Kishi K, Takahashi S, Gondo H et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997; 19: 461\u2013466.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704645_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1365-2141.2000.01851.x","volume":"108","author":"M Michallet","year":"2000","unstructured":"Michallet M, Tanguy ML, Socie G et al. Second allogeneic heamtopoietic transplantation in relapsed acute and chronic leukemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM). Br J Haematol 2000; 108: 400\u2013407.","journal-title":"Br J Haematol"},{"key":"BF1704645_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/BF02982050","volume":"75","author":"A Tomonari","year":"2002","unstructured":"Tomonari A, Iseki T, Ooi J et al. Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients in a single institution. Int J Hematol 2002; 75: 318\u2013323.","journal-title":"Int J Hematol"},{"key":"BF1704645_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-identical sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BF1704645_CR23","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704645_CR24","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V75.12.2459.2459","volume":"75","author":"K Atkinson","year":"1990","unstructured":"Atkinson K, Horowitz MM, Gale RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459\u20132464.","journal-title":"Blood"},{"key":"BF1704645_CR25","doi-asserted-by":"crossref","DOI":"10.1007\/b97377","volume-title":"Survival Analysis: Techniques of Censored and Truncated Data","author":"JP Klein","year":"2003","unstructured":"Klein JP, Moeschberger ML . Survival Analysis: Techniques of Censored and Truncated Data. Springer-Verlag: New York, NY, 2003."},{"key":"BF1704645_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life tables. J R Stat Soc Ser B 1972; 34: 187\u2013202.","journal-title":"J R Stat Soc Ser B"},{"key":"BF1704645_CR27","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#","volume":"18","author":"PK Andersen","year":"1999","unstructured":"Andersen PK, Klein JP, Zhang M-J . Testing for center effects in multi-center survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med 1999; 18: 1489\u20131500.","journal-title":"Stat Med"},{"key":"BF1704645_CR28","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(02)08272-7","volume":"359","author":"TG Clark","year":"2001","unstructured":"Clark TG, Altman DG, De Stavola BL . Quantification of the completeness of follow up. Lancet 2001; 359: 1309\u20131310.","journal-title":"Lancet"},{"key":"BF1704645_CR29","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar et al. Engraftment of allogeneic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531\u20134536.","journal-title":"Blood"},{"key":"BF1704645_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1365-2141.2001.03150.x","volume":"115","author":"R Pawson","year":"2001","unstructured":"Pawson R, Potter MN, Theocharous P et al. Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG\u00b1Ida) and second allogeneic stem cell transplant. Br J Haematol 2001; 115: 622\u2013629.","journal-title":"Br J Haematol"},{"key":"BF1704645_CR31","first-page":"3702","volume":"95","author":"RE Champlin","year":"2000","unstructured":"Champlin RE, Schmitz N, Horowitz MM et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000; 95: 3702\u20133709.","journal-title":"Blood"},{"key":"BF1704645_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175\u2013181.","journal-title":"N Engl J Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704645","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704645.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704645.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:07:13Z","timestamp":1734516433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,23]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,10,1]]}},"alternative-id":["BF1704645"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704645","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,23]]},"assertion":[{"value":"27 January 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}